Comparing these dysregulated genes in RTT to those dysregulated in mouse models of MDS identified a common subset of transcripts dysregulated in an opposing manner, demonstrating that the transcriptome is responsive to MeCP2 levels [20, 29–31]. The gene discussed is MECP2; the disease is myelodysplastic syndrome.